Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot-Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility

American Journal of Hospice and Palliative Medicine

Volumn 30, Issue 6, 2013, Pages 523-531

  Aggarwal, S K ^a   Carter, G T ^b   Sullivan, M D ^b   Zumbrunnen, C ^c   Morrill, R ^c   Mayer, J D ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

cannabinoid medicine; cannabinopathic medicine; CDC HRQoL 14; complementary and alternative medicine; health related quality of life; medical cannabis; SF 36; symptom management

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ADULT; ARTICLE; CANNABINOID MEDICINE; CANNABINOPATHIC MEDICINE; CDC HRQOL-14; CHRONIC DISEASE; COMPLEMENTARY AND ALTERNATIVE MEDICINE; DAILY LIFE ACTIVITY; EPIDEMIOLOGY; FEMALE; HEALTH-RELATED QUALITY OF LIFE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; PHYTOTHERAPY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; SYMPTOM MANAGEMENT; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

CANNABINOID MEDICINE; CANNABINOPATHIC MEDICINE; CDC HRQOL-14; COMPLEMENTARY AND ALTERNATIVE MEDICINE; HEALTH-RELATED QUALITY OF LIFE; MEDICAL CANNABIS; SF-36; SYMPTOM MANAGEMENT;

ACTIVITIES OF DAILY LIVING; ADULT; CANNABIS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PHYTOTHERAPY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SAMPLING STUDIES; TREATMENT OUTCOME; WASHINGTON; YOUNG ADULT;

EID: 84883179434     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909112454215     Document Type: Article

References (33)

1. Wang T,Collet J,Shapiro S,Ware MA.Adverse effects of medical cannabinoids: a systematic review.Can Med Assoc J. 2008;178 (13): 1669-1678.
2. Aggarwal SK,Carter GT,Sullivan MD,Morrill R,ZumBrunnen C,Mayer JD.Medicinal use of cannabis in the United States: historical perspectives, current trends, and future directions.J Opioid Manag. 2009;5 (3): 153-168.
3. Vettor R,Pagotto U,Pagano C,Pasquali R.Here, there and everywhere: the endocannabinoid system.J Neuroendocrinol. 2008;20 (suppl 1): iv-vi.
4. PacherPBatkaiSKunosG. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3):389-462. http://pharmrev.aspetjournals.org/cgi/reprint/58/3/389.pdf. Accessed April 6, 2012.
5. ChildCMitchellTFAbramsDI.Patterns of therapeutic marijuana use in two community-based cannabis buyers' cooperatives. [abstract no. 60569] Proceedings of the 12th World Conference on AIDS, Geneva, Switzerland, June 1998; 12: 1105. Abstract at: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102232518.html. Accessed April 6, 2012.
6. Harris D,Jones RT,Shank R, et al.Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members.J Addict Dis. 2000;19 (3): 89-103.
7. Gieringer D.Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Grotenhermen FRusso E, ed. Binghamton, NY: Haworth Press; 2001:153-170.
8. Corral VL.Differential effects of medical marijuana based on strain and route of administration: a three-year observational study.JCANT. 2001;1 (3-4): 43-59.
9. Chapkis W,Webb RJDying to Get High: Marijuana as Medicine. New York, NY: New York University Press; 2008:.
10. ONDCP. 2008 Marijuana Sourcebook. Marijuana: The Greatest Cause of Illegal Drug Abuse. Office of National Drug Control Policy Executive Office of the President. July 2008. Marijuana 08-1 [07-29]. http://www.justice.gov/dea/statistics/Marijuana_2008.pdf. Accessed April 6, 2012.
11. Reinman ACannabis Care: Medical Cannabis Facilities as Health Service Providers. Berkeley, CA: School of Social Welfare/Alcohol Research Group, University of California; 2006:.
12. Reinman A.Medical cannabis patients: patient profiles and health care utilization patterns.Complement Health Pract Rev. 2007;12 (1): 31-50.
13. ReinmanA. Cannabis as a substitute for alcohol and other drugs. Harm Reduct J. 2009;6:35. doi:10.1186/1477-7517-6-35. http://www.harmreductionjournal.com/content/6/1/35, Accessed April 6, 2012.
14. "Mental Health Surveillance Across the CDC". http://www.cdc.gov/mentalhealth/about_us/surveillance.htm. Accessed April 6, 2012.
15. McHorney CA.Health status assessment methods for adults: past accomplishments and future challenges.Annu Rev Public Health. 1999;20:309-335.
16. Idler EL,Benyamini Y.Self-rated health and mortality: a review of twenty-seven community studies.J Health Soc Behav. 1997;38 (1): 21-37.
17. Ware JE,Snow KK,Kosinski M,Gandek BSF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute; 1993:.
18. Ware JE,Kosinski M,Keller SD.Boston, MA: The Health Institute; 1994:.
19. Measuring Healthy Days. Atlanta, Georgia: CDC; 2000:.
20. MoriartyDGZackMMKobauR. The Centers for Disease Control and Prevention's Healthy Days Measures-population tracking of perceived physical and mental health over time. Health Qual Life Outcomes. 2003;1:37. doi:10.1186/1477-7525-1-37. http://www.hqlo.com/content/1/1/37.Accessed April 6, 2012.
21. Ryan K,Bissell P,Morecroft C.Narratives about illness and medication: a neglected theme/new methodology within pharmacy practice research. Part II: medication narratives in practice.Pharm World Sci. 2007;29 (4): 353-360.
22. JimenezA. Alfonso Jimenez's Follow Up/Renewal Assessment Tool Questionnaire. http://www.medicalmarijuanaoforangecounty.com/CMS/scripts/esurvey.cgi?action=viewSurvey&id=1173657528. Accessed April 6, 2012.
23. Oregon Medical Marijuana Program (OMMP) Data. Department of Human Services. http://oregon.gov/DHS/ph/ommp/data.shtml. Accessed April 6, 2012.
24. International Association for Cannabinoid Medicines (IACM). http://www.cannabis-med.org. Accessed April 6, 2012.
25. Health Canada-CIHR Medical Marijuana Research Program (Archived). http://web.archive.org/web/20040907145015/http://www.cihr-irsc.gc.ca/e/4628.html. Accessed April 6, 2012.
26. SwiftWGatesPDillonP. Survey of Australians using cannabis for medical purposes. Harm Reduct J. 2005;2:18. doi:10.1186/1477-7517-2-18. http://www.harmreductionjournal.com/content/2/1/18. Accessed April 6, 2012.
27. Grinspoon L,Bakalar JMarihuana: The Forbidden Medicine. New Haven, CT: Yale University Press; 1997:.
28. POZ Medical Marijuana Survey. http://www.poz.com/phpESP/public/survey.php?name=Medical_Marijuana_Survey. Accessed April 6, 2012.
29. Medical Marijuana Patient Survey Form. http://www.onlinepot.org/patientsurvey.htm. Accessed April 6, 2012.
30. Olympia, Washington: Washington State Office of Financial Management;.
31. US Census Bureau. 2006 Population Estimates, Washington. http://factfinder.census.gov/servlet/QTTable?-ds_name=PEP_2006_EST&-qr_name=PEP_2006_EST_DP1&-geo_id=04000US53. Accessed April 6, 2012.
32. Behavioral Risk Factor Surveillance System (BRFSS). Washington State Recent Physically Unhealthy Days, Recent Mentally Unhealthy Days, Recent Activity Limitation, Health Access/ Coverage; 2007. http://apps.nccd.cdc.gov/brfss/page.asp?cat=HS&yr=2007&state=WA#HSandhttp://apps.nccd.cdc.gov/HRQOL/. Accessed April 6, 2012.
33. Leon AC,Hedeker D,Teres JJ.Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment.Stat Med. 2007;26 (1): 110-123.